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USA and 10) Fondation Mérieux, Lyon, FranceAbstractIn about one in a thousand cases, a Campylobacter jejuni infection results in the severe polyneuropathy Guillain–Barré syndrome (GBS). It is
established that sialylated lipo-oligosaccharides (LOS) of C. jejuni are a crucial virulence factor in GBS development. Frequent detection of
C. jejuni with sialylated LOS in stools derived from patients with uncomplicated enteritis implies that additional bacterial factors should be
involved. To assess whether the polysaccharide capsule is a marker for GBS, the capsular genotypes of two geographically distinct GBS-
associated C. jejuni strain collections and an uncomplicated enteritis control collection were determined. Capsular genotyping of C. jejuni
strains from the Netherlands revealed that three capsular genotypes, HS1/44c, HS2 and HS4c, were dominant in GBS-associated strains
and capsular types HS1/44c and HS4c were signiﬁcantly associated with GBS (p 0.05 and p 0.01, respectively) when compared with
uncomplicated enteritis. In a GBS-associated strain collection from Bangladesh, capsular types HS23/36c, HS19 and HS41 were most
prevalent and the capsular types HS19 and HS41 were associated with GBS (p 0.008 and p 0.02, respectively). Next, speciﬁc
combinations of the LOS class and capsular genotypes were identiﬁed that were related to the occurrence of GBS. Multilocus sequence
typing revealed restricted genetic diversity for strain populations with the capsular types HS2, HS19 and HS41. We conclude that
capsular types HS1/44c, HS2, HS4c, HS19, HS23/36c and HS41 are markers for GBS. Besides a crucial role for sialylated LOS of C. jejuni
in GBS pathogenesis, the identiﬁed capsules may contribute to GBS susceptibility.
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p://dx.doi.org/10.1016/j.cmi.2015.05.031IntroductionCampylobacter jejuni is one of the most frequent causes of
bacterial gastroenteritis in humans worldwide [1,2]. In general,
C. jejuni diarrhoea is self-limiting, but a wide spectrum of serious
complications may occur, including bacteraemia, reactive
arthritis and peripheral neuropathies, e.g. Guillain–Barré syn-
drome (GBS) and Miller–Fisher syndrome (MFS) [3].ious Diseases. Published by Elsevier Ltd. All rights reserved
CMI Heikema et al. LOS classes and capsular types are correlated in GBS 852.e2GBS is a post-infectious, immune-mediated disease of the
peripheral nerves, which is characterized by a rapidly pro-
gressive weakness of the limb muscles [4]. About one-quarter
of patients develop additional respiratory failure and auto-
nomic dysfunction and 2–10% of the patients die [5,6]. MFS is
regarded as a variant of GBS in which the weakness is restricted
to the oculomotor muscles [7].
Various studies have investigated which risk factors of
C. jejuni predispose to the development of GBS [8,9]. Currently,
sialylation of lipo-oligosaccharides (LOS) of C. jejuni is the best
characterized virulence factor associated with GBS [10,11]. The
structural similarity (molecular mimicry) between sialylated
C. jejuni LOS and ganglioside structures present on human pe-
ripheral nerves drives a cross-reactive immune response
resulting in immune-mediated nerve damage [10]. In C. jejuni,
genes involved in LOS sialylation are located in the LOS
biosynthesis locus. Variability in gene content in C. jejuni LOS
loci has led to the assignment of several LOS locus classes (A to
S) [12]. Genes involved in the synthesis of sialylated LOS and
ganglioside mimics are present in the LOS classes A, B, C, M
and R [12]. Of these, C. jejuni strains with LOS classes A, B and
C are frequently isolated from stools of patients with GBS and
the LOS classes A and B are associated with GBS and MFS,
respectively [11].
The presence of sialic acid in the LOS, however, does not
appear to be the only bacterial factor involved in the patho-
genesis of GBS. In patients with uncomplicated enteritis, the
prevalence of sialylated C. jejuni strains has been reported to be
up to 63% [11]. We hypothesize that the expression of addi-
tional C. jejuni virulence factors in combination with the pres-
ence of sialylated LOS contributes to the induction of GBS.
Factors that increase the virulence of C. jejuni include the bi-
polar ﬂagella, surface and secreted proteins involved in the in-
vasion of the intestinal epithelium [13], and cytolethal
distending toxin [14]. Genes that encode these virulence fac-
tors, however, are generally conserved and present in strains
derived from both clinical and environmental sources [15,16].
The polysaccharide capsule is a virulence factor that is
associated with cell invasion [17], complement resistance [18]
and immune modulation [19]. The capsule biosynthesis locus
is a highly variable region in the genome of C. jejuni. Diversity in
gene content and gene function, combined with the presence of
phase variable genes in the capsule locus, allows the production
of a broad repertoire of capsular structures [20]. This feature is
the basis of the classical Penner serotyping scheme that divides
C. jejuni into 47 serotypes [21]. Previous studies based on
Penner serotyping showed that the capsular serotypes HS:19,
HS:23/36c and HS:41 are associated with GBS in Japan,
Bangladesh and South Africa, respectively [22–24]. In contrast,
no particular association between the capsular serotype andClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Inneuropathogenicity was observed for GBS-associated strains
from Europe or North America [8,25]. This discrepancy may be
explained by the observation that GBS-associated C. jejuni
strains in Japan, Bangladesh and South Africa had a genetically
related background whereas the strains in Europe and the USA
were more heterogeneous.
Recently, capsular genotyping was introduced as a fast,
readily available and reliable method to assess the capsular type
in C. jejuni [26]. Compared with capsule-based serotyping,
capsular genotyping is not sensitive to variations in capsule gene
expression or inﬂuenced by genes or gene products outside the
capsule locus. With the availability of two large and geograph-
ically distinct GBS-associated strain collections, we determined
whether variation in the C. jejuni capsular genotype is involved
in the risk of developing GBS. The capsular genotype deﬁned by
multiplex PCR was determined in collections of C. jejuni strains
isolated from Dutch patients with GBS or MFS, Dutch patients
with enteritis (control patients) and Bangladeshi patients with
GBS or MFS. The capsular type was related to the LOS class to
determine whether particular LOS class/capsular type combi-
nations were more prevalent among GBS/MFS-associated
strains compared with enteritis-associated strains. In addition,
multilocus sequence typing (MLST) was performed to assess
the genetic relation between strains.Materials and methodsStrain collection, culture conditions and DNA isolation
In this study, Dutch and Bangladeshi GBS-associated C. jejuni
strain collections and a Dutch enteritis-associated control
strain collection were used. The Dutch GBS collection
comprised 32 GBS-associated and ﬁve MFS-associated strains,
which were isolated from stools of primarily Dutch patients.
Among these are three GBS-associated strains from patients
from the Netherlands Antilles and one from Belgium. The GBS-
associated strain collection from Bangladesh consisted of 30
strains. The Dutch enteritis-associated strains were isolated
from patients with diarrhoea in the Netherlands and were from
two different provenances. The strains in the ﬁrst enteritis
collection (n = 21) were isolated between 1990 and 1999 and
have been previously described [11]. A second enteritis
collection originates from a Dutch study performed by the
Rijksinstituut voor Volksgezondheid en Milieu in 2002–2003,
on behalf of a national Campylobacter and Salmonella surveillance
study [27,28]. From this large collection, we selected 122 en-
teritis strains that matched our GBS/MFS-associated strains
based on age (decade) and sex. Hence, we selected three or
four age- and sex-matched enteritis control strains per GBS/
MFS case. There were no signiﬁcant differences in thefectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 852.e1–852.e9
852.e3 Clinical Microbiology and Infection, Volume 21 Number 9, September 2015 CMIdistribution of the various capsular genotypes between the two
enteritis collections. Therefore, the two enteritis strain col-
lections were combined in this study and referred to as the
uncomplicated enteritis-associated strain collection (n = 143).
For the Dutch GBS-, MFS- and enteritis-associated strains, LOS
class typing (A, B, C, D and E) was performed previously [11]
(A. P. Heikema, D. Horst-Kreft, R. Louwen, R. Huizinga, M.
Gilbert, J. Li, C. T. Parker and H. P. Endtz). The LOS class of 10
of the GBS-associated C. jejuni strains derived from Bangladesh
was determined previously [24]. For the remaining 20 strains,
the LOS class was newly assessed. Campylobacter jejuni strains
were cultured from stocks kept at –80°C and maintained on
Colombia blood agar plates (Becton Dickinson BV, Alphen aan
den Rijn, the Netherlands) supplemented with 10 mg/L van-
comycin in a micro-aerobic atmosphere at 37°C. DNA was
isolated from overnight-grown C. jejuni, using a DNeasy blood
and tissue kit (Qiagen, Venlo, the Netherlands) as described by
the manufacturer’s protocol.
LOS locus class PCR
Genotyping was performed for LOS classes A, B, C, D and E
using standard PCR. Primers used are based on the DNA
sequence of unique genes or regions of the LOS locus classes
involved and were previously described [11].
Multiplex PCR-based capsule analysis
Capsular genotyping was performed as described previously
[26]. In short, based on the sequence of 17 capsule loci, unique
regions were identiﬁed and speciﬁc primer pairs that recognize
each Penner serotype were designed. The primer pairs were
divided in two mixes in such a way that the expected amplicons
differed at least 20 bp from one another. Standard PCR was
performed and the PCR products were separated on 2%FIG. 1. Capsular genotypes in Guillain–Barré syndrome/Miller–Fisher syndro
PCR was used to determine the capsular type of 37 GBS/MFS-associated (bl
strains derived from Dutch patients and 30 GBS-associated strains derived fr
main capsular types can be distinguished. Chi square and Fisher exact tests
between the Dutch GBS/MFS patients and the enteritis group. UT, untype
considered as statistically signiﬁcant.
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectagarose gels using a 50-bp DNA ladder (Fermentas, Landsmeer,
the Netherlands) to assess the size of each amplicon.
Multilocus sequence typing
Multilocus sequence typing, which relies on the partial
sequencing of seven housekeeping genes, was performed as
described elsewhere [8]. A dendrogram was constructed using
BIONUMERICS software (Applied Maths NV, Sint-Martens-Latem,
Belgium). Pairwise alignment of the sequences of the separate
MLST alleles was performed. The dendrogram was generated
using the unweighted pair group method with arithmetic mean
clustering.
Statistical analysis
Fisher exact and chi-square tests were performed using PRISM
software (GraphPad, La Jolla, CA, USA). Two-sided p  0.05
was considered to be statistically signiﬁcant.ResultsValidation of the capsular genotyping method
The capsular genotype determined by PCR was compared to
the serotype for our C. jejuni strains with known Penner
serotype (n = 40). The serotype did not match the genotype in
six cases and in one case the serotype was not included in the
multiplex capsule PCR (data not shown). Full genome sequence
data were available for four of six strains with a mismatch be-
tween capsular serotype and genotype. BLAST analysis of the
capsule locus region revealed homology to strains with sero-
types that matched the identiﬁed genotype and not the sero-
type in all four cases (data not shown). Overall, we found a
speciﬁcity of 95% and a sensitivity of 100% for strains (n = 39)me (GBS/MFS) -associated and enteritis-associated strains. A multiplex
ack bars) and 143 enteritis-associated (white bars) Campylobacter jejuni
om patients with GBS from Bangladesh (grey bars). With this PCR, 17
were used to compare the frequency of speciﬁc capsular genotypes
able; mix, more than one capsular genotype detected. p  0.05 was
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 852.e1–852.e9
CMI Heikema et al. LOS classes and capsular types are correlated in GBS 852.e4with serotypes covered in the genotyping method. Therefore,
we concluded that the genotyping method is a reliable method
to determine the capsular type in C. jejuni.
Six capsular genotypes are dominant in GBS/MFS-
associated C. jejuni strains
In the Dutch GBS/MFS-associated strains, a capsular genotype
could be assigned for all strains whereas in the Dutch enteritis-
associated strains a capsular genotype could be assigned for 120
of 143 (83%) of the strains. Twenty-two strains in the enteritis
group failed to produce amplicons and in one case a mix of two
capsular types (HS1/HS41) was found. In the Dutch GBS/MFS
collection, nine different capsular types were identiﬁed of which
three capsular types; HS4c, HS2 and HS1/44c were dominant
(Fig. 1). In the Dutch enteritis strain collection, a broader panel
of 15 different capsular types was identiﬁed of which capsules
HS4c, HS8/17 and HS2 were most prevalent (Fig. 1). When
GBS/MFS-associated C. jejuni strains and enteritis-associated
strains were compared, capsular type HS4c (p 0.01; chi-
square test) and HS1/44c (p 0.05; chi-square test) signiﬁcantly
associated with GBS/MFS (Fig. 1). No association with a speciﬁc
capsular type was observed for the MFS strains. In the ﬁve MFS-
associated strains, four different capsular types were detected;
HS2, HS4c (in two cases), HS10 and HS23/36c. When com-
bined, 28/37 (76%) of the GBS/MFS-associated strains from the
Netherlands had capsular type HS1/44c, HS2 or HS4c,
compared with 50/143 (35%) in the enteritis control strains
(p < 0.0001; chi-square test).FIG. 2. Correlation of lipo-oligosaccharide (LOS) class and capsular genotype.
type. The six main capsular types observed in the Guillain–Barré syndrome
Campylobacter jejuni strains from the Netherlands. The chi-square tests were
capsular type combinations between the GBS/MFS and enteritis strains. Here
C. jejuni strains from BD. Others, capsular types that did not belong to the gro
strain collections but that could be determined with the multiplex capsule PC
considered as statistically signiﬁcant.
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and InTo determine whether the dominant capsular types identi-
ﬁed in the GBS/MFS-associated strain collection from the
Netherlands were also prominent in GBS-associated strains
from another geographical area, capsular genotyping was per-
formed on 30 GBS-associated strains isolated from patients
from Bangladesh. In these strains, a capsular type could be
assigned for 28/30 (93%) of the strains and capsular types HS23/
36c, HS19 and HS41 were dominant (Fig. 1). In a randomly
selected uncomplicated enteritis control group from
Bangladesh, 0/39 (0%) of the C. jejuni strains had the capsular
type HS19, 11/39 (28%) had HS23/36 and in 1/39 (3%) capsular
type HS41 was identiﬁed (Z. Islam, personal communications).
The capsular types HS19 and HS41 signiﬁcantly associated with
GBS in Bangladesh when compared with enteritis (p 0.008 and
p 0.02, respectively; chi-square test). Capsular type HS41 was
only found in strains from Bangladesh whereas capsular types
HS23/36c and HS19 were also observed in the Dutch strain
collections. When combined, 56/67 (84%) of the GBS/MFS-
associated C. jejuni strains either had capsular type HS1/44c,
HS2, HS4c, HS19, HS23/36c or HS41 (from here on referred to
as GBS/MFS-related capsular types).
Sialylated LOS classes and speciﬁc capsular genotypes
are correlated
Upon correlation of LOS class and capsular genotype in the
GBS/MFS strain collection from the Netherlands, we observed
that all but one strain with the LOS class A, B or C had the
GBS/MFS-related capsular types (Fig. 2a). A particularFor each strain, the LOS class was correlated to the respective capsular
/Miller–Fisher syndrome (GBS/MFS) strain collection are depicted. (a)
used to assess whether there were signiﬁcant differences in LOS class/
to, the six main capsular types were compered to others and UT. (b)
up of six dominant capsular types observed in the GBS/MFS-associated
R; NL, The Netherlands; BD, Bangladesh; UT, untypeable; p  0.05 was
fectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 852.e1–852.e9
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FIG. 3. Dendrogram of MLST genotype variation of C. jejuni
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generated from MLST sequence type data of 58 GBS-, 5 MFS- and
51 enteritis-associated C. jejuni strains with either an LOS class A,
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CMI Heikema et al. LOS classes and capsular types are correlated in GBS 852.e6distribution pattern was observed when LOS class and capsular
type were combined. In the GBS/MFS collection, strains with
LOS class A were typed HS1/44c, HS2, HS4c or HS19, in strains
with LOS class B, capsular types HS2 and HS4c were the most
prominent and LOS class C strains, mostly had capsular type
HS1/41 or HS2 (Fig. 2a). In the enteritis control collection,
approximately the same capsule distribution was observed for
LOS class A strains. In contrast, for the class B and C strains,
similar capsular types were only found for a subset of the en-
teritis strains when compared with the GBS/MFS strains. A
distinct capsular type was found in 9/28 (32%) of the LOS class
B strains and 18/34; 53% of the class C strains had a capsular
type that did not belong to the GBS/MFS-related capsule group
(p 0.01; GBS/MFS versus enteritis; chi-square). In enteritis
strains with LOS class B, there was diversity in the remaining
capsular types but in the LOS class C strains, capsular type HS8/
17 was detected in 9/18 (50%) of the strains, which did not
belong to the GBS/MFS-related capsule group.
In enteritis strains with LOS class D, capsular type HS53 was
dominant (9/31; 29%; HS53 is not present in class D strains of
the GBS/MFS collection) whereas capsular types within class E
strains were diverse (data not shown). It should be noted that
LOS class D and E loci do not possess the genes encoding
proteins that are involved in LOS sialylation and are necessary
to produce ganglioside mimics.
Lipo-oligosaccharide genotyping of 20 newly isolated GBS-
associated C. jejuni strains from Bangladeshi patients resulted in
the identiﬁcation of ten strains with LOS class A and ten strains
with LOS class B. When LOS class and capsular type of the GBS-
associated strains derived from Bangladeshi patients (n = 30)
were correlated, all strains with capsular type HS41 or HS19
correlated with LOS class A, whereas all the strains with the
HS23/36c capsular type correlated with LOS class B (Fig. 2b).
A genetic linkage between LOS/capsule combinations
Multilocus sequence typing was performed on all (n = 67) GBS-
associated and MFS-associated strains and on 84/143 (59%) of
the enteritis-associated strains. The 84 enteritis control strains
on which MLST was performed comprised 60% sialylated
strains and 40% non-sialylated strains. These percentages are
representative for the whole enteritis control collection of 143
strains. A total of 76 different sequence types were identiﬁed,
which were classiﬁed into 21 clonal complexes. The C. jejuni
clonal complex ST-21 was most prominent (29/151; 19%),
followed by ST-206 (16/151; 11%) and ST-22 (15/151; 10%). In
13 cases, the MLST represented a singleton. In the GBS
collection, the clonal complexes ST-21 and ST-22 were the
most common (both 10/67; 15%) followed by ST-403 (9/67;
13%). A minimum spanning tree, in which our MLST data were
combined with MLST data of C. jejuni isolates from sporadicClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Incases of human enteritis present in the Oxford C. jejuni MLST
database (n = 4066), showed that our GBS/MFS-associated and
enteritis-associated strains were widely spread within the total
C. jejuni MLST population (see Supplementary material, Fig. 1).
GBS/MFS-associated as well as enteritis-associated control
strains were present within the same clonal complexes.
To assess whether the LOS class/capsular type co-
occurrence within one strain was due to a closely related ge-
netic background, in particular for the strains that carry genes
involved in LOS sialylation, a dendrogram was generated using
strains from both the Netherlands and Bangladesh, which had
LOS loci classes A, B or C (Fig. 3). The same genetic back-
ground, ST-21, was frequently observed for strains with
capsular types HS1/44c and HS2 and LOS class C (18/29; 62%).
Most HS8/17 strains with LOS class C (6/7; 86%) also belonged
to ST-21. The HS4c strains with LOS class A or B were pre-
dominantly present in four genetic backgrounds: ST-206, ST-48,
ST-61 and ST-508 (30/35; 86%). A strong individual genetic
relationship was observed for LOS class A strains with capsular
type HS41 (n = 6) and HS19 (n = 13). All HS19 strains belonged
to ST-22 whereas all HS41 strains belonged to ST-362. The
strains with capsular type HS23/36c were more widely spread
within the dendrogram. Most (11/14; 78%), however, belonged
to two MLST clonal complexes, ST403 and ST-42 (Fig. 3). One
MLST clonal complex, ST-508, contained GBS-associated
strains only but overall MLST typing did not discriminate
strains carrying genes involved in LOS sialylation when GBS/
MFS-associated and enteritis-associated strains were compared.DiscussionWe identiﬁed a group of six main capsular genotypes HS1/44c,
HS2, HS4c, HS19, HS23/36c and HS41 in two large,
geographically distinct GBS/MFS-associated C. jejuni strain col-
lections. In a predominantly Dutch collection (n = 37), capsular
genotypes HS1/44c, HS2 and HS4c were dominant. Of these,
capsular type HS4c and HS1 associated with the neuro-
pathogenicity. In a GBS-associated strain collection from
Bangladesh (n = 30), three other capsular genotypes, HS19,
HS23/36c and HS41 were abundant and capsular type HS19 and
HS41 associated with GBS.
In the GBS/MFS group, a capsular type was assigned to all but
two strains whereas 22 strains in the enteritis group failed to
produce amplicons. The 24 strains in total that did not produce
amplicons probably have a capsular type distinct from the 17
major capsular types that were tested. Multiple ampliﬁcation
fragments found in one case might be due to a mix of two strains,
gene translocations between particular capsular types or multi-
ple capsule operons in one genome. Earlier, we reported that nofectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 852.e1–852.e9
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serotype in a collection of strains from GBS patients in the
Netherlands [8]. The discrepancy with the current results may
be explained by the fact that serotyping is sensitive to capsule
expression whereas genotyping is not. For example, phase
variation and intragenic mutations that lead to premature stop
codons result in more diversity in capsular serotypes compared
with the capsular genotypes [26]. Furthermore, for some se-
rotypes, the LOS plays a role in sero-diversity [29]. Reduction of
the number of capsular genotypes compared with serotypes,
enhanced sensitivity of the genotyping method compared with
serotyping and, in particular, more power due to an expanded
GBS/MFS-associated C. jejuni strain collection are factors that
explain why an association between capsular genotypes and GBS
was found in the current study and not in the study performed
by Dingle et al. [8]. The association with GBS and the capsular
types HS1/44c and HS4c reported in our study could be biased
by a suboptimal enteritis control group, in which case it would
under-represent HS1/44c and HS4c strains. Geographical dif-
ferences in capsular type distribution has been reported [30] but
with 9% of HS1/44c and 26% of HS4c strains, our Dutch enteritis
collection certainly does not under-represent the capsule pro-
portion in Europe (9.1% HS1/44c, 17.3% HS4c) and North
America (9.3% HS1/44c, 23.4% HS4c) [30].
As great diversity between the capsular loci and multiple
rearrangements between capsular genes has been reported for
the capsular types HS1/44c, HS2, HS4c, HS19, HS23/26c and
HS41 [20,26], it remains unclear whether particular genes or
mutations in particular genes within GBS-associated capsular
types may promote the development of GBS.
Our current data, derived from a three-fold expanded
Bangladeshi strain collection, conﬁrm that HS23/36c is a prev-
alent capsular type among GBS-associated strains from
Bangladesh [24,31]. This capsular type, however, was also
frequently observed in enteritis-associated strains from
Bangladesh and was not associated with GBS when compared
with enteritis.
When we combined the results of the LOS classiﬁcation with
the capsular genotyping, a striking correlation was observed.
Capsular types HS19 and HS41 correlated solely with LOS class
A, HS23/36c often with LOS class B, HS1/44c was predomi-
nantly found in strains with LOS class A and C and capsular type
HS4c mostly associated with LOS class A and B strains. In
agreement with our data, strains with the HS19 (ST-22), HS23/
36c (ST-403) and HS41 (ST-362) capsular type represent
genetically related populations [24,32,33]. A correlation be-
tween capsular type and LOS class in these strains is therefore
to be expected. The frequent sharing of capsular types in GBS-
associated strains that differ in MLST, observed in this study,
argues more strongly for a role of the capsule in GBS induction.Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and InfectThe bi-functionality of some of the enzymes involved in poly-
saccharide biosynthesis may additionally explain why particular
LOS loci and capsule types are linked. In C. jejuni, a phosphatase
encoded by the LOS locus gene cj1152 is active in the biosyn-
thesis of both, LOS and capsule [20]. Additionally, gmhA in the
LOS locus and gmhA2 in the capsule locus have duplicate
functions [20]. More in-depth studies on gene functionality of
LOS and capsule biosynthesis genes are needed to explain why
certain LOS classes and capsules are genetically linked together.
MLST analysis showed that the Dutch and Bangladeshi HS19
(ST-22) strains and the Bangladeshi HS41 (ST-362) strains
originate from a similar genetic lineage to that of the HS19
strains frequently isolated in Japan [34] and HS41 strains that
were associated with GBS in South Africa, respectively [35].
Moreover, the Japanese and South African GBS strains were all
LOS class A. The preservation of stable lineages in HS19 and
HS41 strains is probably linked with DNase activity or defects in
the DNA transformation mechanism resulting in non-naturally
transformable strains [36]. The described feature of C. jejuni
to exchange genes and even entire loci due to horizontal gene
transfer [20,37] explains the observed variations in LOS class
and capsular type within identical MLST clonal complexes.
Overall, MLST failed to segregate strains associated with GBS
from strains associated with gastroenteritis.
Does capsule type discriminate between neuropathogenic
and uncomplicated diarrhoeal strains of C. jejuni? In particular for
the LOS classes B and C the answer is afﬁrmative. LOS class B
and C strains with capsular types other than HS1/44c, HS2,
HS4c or HS23/36c were predominantly detected in the
enteritis-associated control strain collection. Capsular type HS8/
17 and HS31 for example were observed in enteritis-associated
strains with LOS class A, B or C but not in GBS-associated
strains with similar LOS classes. Such strains may therefore be
considered to be less potent with regard to GBS induction.
Certainly, more comparative capsule studies, including functional
studies, are needed to determine if and how a particular capsular
type might contribute to GBS development. In conclusion, we
demonstrate that the combination of LOS loci that contain genes
involved in LOS sialylation with the capsular types HS1/44c, HS2,
HS4c, HS19, HS23/36c and HS41 are associated with the
development of GBS and MFS and are therefore markers for
these neurological diseases. The observation that similar
capsular types are prevalent in GBS-associated strains with
genetically unrelated lineages strongly argues for a role of the
capsule in GBS inductions. A distinct capsular type other than
the six capsular types identiﬁed in this study may in part explain
why not all infections with C. jejuni that carry ganglioside mimics
lead to GBS. The geographical differences in C. jejuni capsular
type distribution in GBS patients reported here needs to be
conﬁrmed in other comparative studies.ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 852.e1–852.e9
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